Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Inflammation in Cardiovascular Disease

  • Park, Chul Soo (Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Yoido St. Mary's Hospital)
  • Received : 2017.04.28
  • Accepted : 2017.05.05
  • Published : 2017.05.31
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007;49:2129-38. https://doi.org/10.1016/j.jacc.2007.02.052
  2. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638-43. https://doi.org/10.1016/j.jacc.2005.02.054
  3. Kim BJ, Cho SH, Cho KI, Kim HS, Heo JH, Cha TJ. The combined impact of neutrophil-to-lymphocyte ratio and type 2 diabetic mellitus on significant coronary artery disease and carotid artery atherosclerosis. J Cardiovasc Ultrasound 2016;24:115-22. https://doi.org/10.4250/jcu.2016.24.2.115
  4. Nam SH, Kang SG, Song SW. The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic Korean males: a cross-sectional study. Biomed Res Int 2017;2017:1989417.
  5. Cho KI, Ann SH, Singh GB, Her AY, Shin ES. Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drugeluting stent. PLoS One 2015;10:e0133934. doi:10.1371/journal.pone.0133934. eCollection 2015.
  6. Shin HC, Jang JS, Jin HY, et al. Combined use of neutrophil to lymphocyte ratio and c-reactive protein to predict clinical outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention. Korean Circ J 2017:47;383-91. https://doi.org/10.4070/kcj.2016.0327
  7. Gislason G, Jacobsen S, Rasmussen J, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 2006;113:2906-13. https://doi.org/10.1161/CIRCULATIONAHA.106.616219
  8. Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 2013;61:404-10. https://doi.org/10.1016/j.jacc.2012.10.027
  9. O'Donoghue ML, Glaser R, Cavender MA, et al. Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial. JAMA 2016;315:1591-9. https://doi.org/10.1001/jama.2016.3609